Skip to main content
Research Responsibilities and Compliance

Institutional Biosafety Committee

An Institutional Biosafety Committee (IBC) is required at all institutions that receive funding from the National Institutes of Health (NIH) for research involving recombinant DNA molecules. Regardless of funding source, all recombinant DNA research at The Ohio State University must be conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules and must be registered with the IBC.

The university IBC is further charged with reviewing and approving research conducted with microorganisms pathogenic to humans, plants, or animals. This review is conducted pursuant to the Centers for Disease Control and Prevention/NIH publication; Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition.

The IBC in conjunction with Environmental Health and Safety will also provide guidance to the Ohio State research community regarding the proper acquisition, handling, transfer, and disposal of potentially hazardous or regulated biological materials. The Office of Responsible Research Practices (ORRP) will also provide assistance with IBC registrations and applications.

Meeting Dates and Deadlines

New applications, responses to deferrals, and any amendments calling for significant changes to approved research require convened committee review and will be discussed at the subsequent monthly meeting. Investigators will receive a response to these submissions within 10 business days of the meeting. All other submissions including exempt applications may be reviewed administratively; approval typically occurs within five business days.

  • Protocols and amendments must be submitted 10 days prior to the meeting date.
  • Human clinical trial protocols must be submitted 14 days prior to the meeting date.

All meeting dates are subject to change or cancellation, contact ORRP at 614-688-8457 to confirm dates.

Location: Meetings will be held virtually until further notice
Time: 10 a.m.

  • January 11, 2024
  • February 8, 2024
  • March 14, 2024
  • April 11, 2024
  • May 9, 2024
  • June 13, 2024
  • July 11, 2024
  • August 8, 2024
  • September 12, 2024
  • October 10, 2024
  • November 14, 2024
  • December 12, 2024


Institutional Biosafety Officer

David Puskas